Global Point of Care Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Global

Share This On

Home > Reports > Medical Devices > Healthcare > Global Point of Care Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
CHAPTER 1. INTRODUCTION

    1.1. Market Definition

    1.2. Executive Summary

    1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

    2.1. Secondary Research

    2.2. Primary Research

    2.3. Analytic Tools and Model

    2.4. Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5. Expert Validation

    2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

    3.1. Industry Value Chain Analysis

    3.2. Porter's Five Force Analysis

            3.2.1. Bargaining Power of Buyers

            3.2.2. Bargaining Power of Suppliers

            3.2.3. Threats of Substitutes

            3.2.4. Threats of New Entrants

            3.2.5. Degree of Competition

    3.3. PESTLE Analysis

            3.3.1. Political

            3.3.2. Economical

            3.3.3. Social

            3.3.4. Technological

            3.3.5. Legal

            3.3.6. Environmental

    3.4. SWOT Analysis

            3.4.1. Strengths

            3.4.2. Weakness

            3.4.3. Opportunities

            3.4.4. Threats

    3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

    4.1. Market Drivers

            4.1.1. Increase in incidence of target diseases

            4.1.2. Growing usage of home-based POC devices

            4.1.3. Technological advancements and new product launches

            4.1.4. Rise in infectious diseases in developing countries

    4.2. Market Restraints & Challenges

            4.2.1. The high cost of devices

            4.2.2. Lack of knowledge on the usage on POC devices

            4.3.3. Stringent and time-consuming policies

    4.3. Market Opportunities

            4.3.1. The rise in emerging markets

            4.3.2. Increase in POC tests with multiplexing capabilities

CHAPTER 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY

PLATFORM

    5.1 Introduction

    5.2 Molecular Diagnostics

    5.3 Dipsticks

    5.4 Microfluidics

    5.5 Lateral Flow Assays

    5.6 Immunoassays

CHAPTER 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY PRODUCT

    6.1. Introduction

    6.2. Tumour/Cancer Marker Testing Products

    6.3. Urinalysis Testing Products

    6.4. Cholesterol Testing Products

    6.5. Haematology Testing Products

    6.6. Drugs-of-Abuse Testing Products

    6.7. Faecal Occult Testing Products

    6.8. Other POC Products

    6.9. Cardiometabolic Testing Products

            6.9.1 Cardiac Marker Testing Products

            6.9.2 Blood Gas/Electrolytes Testing Products

            6.9.3 HBA1C Testing Products

    6.10. Glucose Monitoring Products

            6.10.1 Strips

            6.10.2 Meters

            6.10.3 Lancets & Lancing Devices

    6.11. Infectious Disease Testing Products

            6.11.1. Influenza Testing Products

            6.11.2. HIV Testing Products

            6.11.3. Hepatitis C Testing Products

            6.11.4. Sexually Transmitted Disease (STD) Testing Products

            6.11.5. Healthcare-Associated Infection (HAI) Testing Products

            6.11.6. Respiratory Infection Testing Products

            6.11.7. Tropical Disease Testing Products

            6.11.8. Other Infectious Disease Testing Products

    6.12. Coagulation Testing Products

            6.12.1.PT/INR Testing Products

            6.12.2. Activated Clotting Time (ACT/APTT) Testing Products

    6.13. Pregnancy and Fertility Testing Products

            6.13.1. Pregnancy Testing Products

            6.13.2. Fertility Testing Products

CHAPTER 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY

PRESCRIPTION MODE

    7.1 Introduction

    7.2 Prescription-Based Testing

    7.3 OTC Testing

CHAPTER 8. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY END USER

    8.1. Introduction

    8.2. Professional Diagnostic Centers

            8.2.1. Outpatient Healthcare & Ambulatory Care Settings

            8.2.2. Hospitals/Critical Care Centers

    8.3. Home Care

    8.4. Research Laboratories

    8.5. Other End Users

CHAPTER 9. GLOBAL POINT OF CARE DIAGNOSTICS MARKET- BY

GEOGRAPHY

    9.1. Introduction

    9.2. North America

            9.2.1. U.S.

            9.2.2. Canada

            9.2.3. Mexico

            9.2.4. Costa Rica

    9.3. South America

            9.3.1. Brazil

            9.3.2. Argentina

            9.3.3. Chile

            9.3.4. Columbia

            9.3.5. Others

    9.4. Europe

            9.4.1. U.K.

            9.4.2. Germany

            9.4.3. France

            9.4.4. Italy

            9.4.5. Spain

            9.4.6. Russia

            9.4.7. Netherlands

            9.4.8. Switzerland

            9.4.9. Poland

            9.4.10. Others

    9.5. APAC

            9.5.1. China

            9.5.2. Japan

            9.5.3. India

            9.5.4. South Korea

            9.5.5. Australia & New Zealand

            9.5.6. Malaysia

            9.5.7. Singapore

            9.5.8. Others

    9.6. Middle East & Africa

            9.6.1. UAE

            9.6.2. Saudi Arabia

            9.6.3. Iran

            9.6.4. Iraq

            9.6.5. Qatar

            9.6.6. South Africa

            9.6.7. Algeria

            9.6.8. Morocco

            9.6.9. Nigeria

            9.6.10. Egypt

            9.6.11. Others

CHAPTER 10. GLOBAL POINT OF CARE DIAGNOSTICS MARKET- COMPANY

PROFILES

    10.1.  Trinity Biotech

    10.2.  PTS Diagnostics

    10.3.  Becton, Dickinson, and Company (BD)

    10.4.  Chembio Diagnostics

    10.5.  Quidel Corporation

    10.6.  EKF Diagnostics

    10.7.  Abbott Laboratories

    10.8.  Johnson & Johnson

    10.9.  Nova Biomedical

    10.10. Instrumentation Laboratory

    10.11. Danaher Corporation

    10.12. Roche Diagnostics

    10.13. Sekisui Diagnostics

    10.14. Siemens

    10.15. AccuBiotech Co., Ltd.

CHAPTER 11. GLOBAL POINT OF CARE DIAGNOSTICS MARKET-

COMPETITIVE LANDSCAPE

    11.1. Market Share Analysis

    11.2. Strategies adopted by top companies

    11.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 12. MARKET INSIGHTS

    12.1. Industry Experts Insights

    12.2. Analysts Opinions

    12.3. Investment Opportunities

CHAPTER 13. APPENDIX

    13.1. List of Tables

    13.2. List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion